header logo image


Page 17«..10..16171819..3040..»

Archive for September, 2020

Eyeing the connection between autism and vision – Spectrum

Friday, September 18th, 2020

The first indication that autism can accompany blindness more often than expected came in a 1956 study of 60 children with retinopathy of prematurity, a condition in which the light-capturing tissue at the back of the eye does not develop properly. Five of these children turned out to be autistic a dramatic result at a time when fewer than 1 in 1,000 children had an autism diagnosis, and high even in light of todays prevalence of about 1 to 2 percent in most countries.

Since then, studies in multiple countries have documented a double-digit prevalence of autism among blind children: 12 percent in Turkey, 17 percent in Sweden and 50 percent of the students whom Jure examined at the school for the blind Gigena attended in Argentina.

These studies are small, each involving only a few dozen to a few hundred people. But a much larger study published this year also links autism and a lack of sight. Researchers in Scotland approached the question from the opposite direction: They combed through national census data on 5.3 million people to show that blindness is about three times as common in autistic children as in their typical peers, and it occurs in autistic adults at 1.5 times the typical frequency.

None of the studies explain the statistics. Do autism and blindness stem from the same biological roots? Some research suggests that autism is closely tied to specific causes of blindness for instance, optic nerve hypoplasia (Gigenas condition), retinopathy of prematurity and anophthalmia (in which one or both eyes fail to develop). The causes of these vision problems may also contribute to autism, experts say.

Lilita wasnt reaching [milestones]. She wasnt making friends, and she didnt communicate well. Lilian Funes

Another possibility is that blindness contributes to autism traits, particularly when a child is born blind, because vision is thought to be critical to the early development of social skills. Young children learn that other people have distinct points of view and emotions by seeing how others react to the world around them. They also learn about social cause and effect through visual relationships, such as when a toddler grabs a toy and pulls it to himself while saying, Mine.

What you have here is something absolutely pivotal for human development, says Peter Hobson, emeritus professor of developmental psychopathology at University College London in the United Kingdom. Children with acquired blindness can still tap this knowledge after they have lost their sight, Hobson says. But those who are born blind may have trouble gaining it in the first place.

This theory is borne out by research showing an association between congenital blindness and autism. For example, 18 of 25 students with congenital blindness at Gigenas school met the criteria for autism in Jures 2016 study, compared with only 1 of 13 with partial or acquired blindness. A similar pattern emerged when he analyzed pooled data from 12 published studies of blindness and autism. The presence of total congenital blindness was the main factor by far that produced autism, he says. Blindness acquired after the first year of life and partial vision were associated with autism less frequently.

In a 1997 study of British schools for the blind, Hobson and his colleagues found that 9 of 24 congenitally blind children without obvious neurological impairments met the criteria for autism; many others had autism traits. Those findings jibe with Jures clinical experience: Within families, children who are completely blind tend to be autistic, whereas their seeing or partially sighted siblings, even identical twins, are not, he says. Im completely convinced that blindness itself conveys a huge possibility of autism.

Researchers who work with blind children have also noticed similarities between their behavior and that of autistic children. In her 1977 book, Insights From the Blind, child psychoanalyst Selma Fraiberg described a girl named Kathie who had been blind since birth. Although bright and socially engaged, Kathie did not engage in imaginative play. And she tended to confuse the pronouns I and you, as well as other terms, such as here and there, come and go, and this and that. Such linguistic reversals, especially of pronouns, are common in young children with autism. Other autism-like behaviors often seen in blind children include repetitive movements, such as rocking back and forth; resistance to change; and echolalia, or repeating another persons words. Fraiberg termed such behaviors blindisms.

Some experts, including Michael Brambring, an emeritus psychologist at Bielefeld University in Germany, have argued that autism traits in blind children are just manifestations of blindness, not autism. What look like the same behaviors may sometimes stem from different prompts. As an example, one mother describes in an essay how her blind daughter would rock back and forth in a way that looked like an autism-like repetitive behavior until she realized her daughter was listening for squeaks in the floorboards. The girl had a different sensory world than a sighted person, and she was just exploring that.

This sort of misperception is widespread, says Pawan Sinha, a vision and autism expert and computational neuroscientist at the Massachusetts Institute of Technology. In 2005, Sinha founded an organization, staffed by surgeons, to restore sight in people with treatable causes of blindness in rural India. He says that many of the blind children he sees are shy at first, though sociable with familiar people. They also have some behaviors reminiscent of autism, such as echolalia. Having met with literally thousands of blind children, blind adults, I simply dont see the signs of high incidences of autism in that population, Sinha says. But he plans to look more closely by surveying autism characteristics in at least 1,000 blind adolescents in India.

Hobson and Jure maintain that autism traits should be seen as signs of autism even if they result from blindness. If you define the syndrome based on the behavior, [then] if you have the behavior, you have to call it autism too, Jure says. Whats more, automatically labeling autism-like behaviors blindisms could lead some clinicians to miss autism in blind children, he adds.

Continue reading here:
Eyeing the connection between autism and vision - Spectrum

Read More...

Waste from the food chain could hold the clue to treating eye infections worldwide – India TV News

Friday, September 18th, 2020

Image Source : INSTAGRAM/BIGGUYSTRI

Waste from the food chain could hold the clue to treating eye infections worldwide

A new laboratory model that can be used to test treatments for preventing and curing eye infections caused by fungi, bacteria and viruses while also reducing the number of animals used in medical research has been developed by researchers, including from India, at the University of Sheffield in the UK. The breakthrough, which will be used to develop novel alternatives to antibiotics to reduce the emergence of antibiotic-resistant superbugs, has been made by engineers and scientists working together at the University of Sheffields Collaboratorium for Antimicrobial Resistance and Biofilms (SCARAB).

In some developing countries, eye infections pose a significant threat resulting in vision impairment or even blindness. Currently, around 285 million people globally are visually impaired and seven million people lose their eyesight each year. Over 90 percent of people affected are from developing countries, according to a press release from the university.

In approximately 80 per cent of these people, the loss of eyesight can be easily avoided with bespoke healthcare solutions that fit with the unique socio-economic conditions prevalent in developing countries.

Using the ex vivo porcine eye model - the eyes of pigs which are deemed as waste by the food industry - researchers can mimic infection in human eyes.

The cornea is the transparent portion in the front of the eye that allows us to see.

Using the ex vivo porcine models researchers were able to study ulcer formation and the development of opacity which leads to the loss of vision in humans.

The new model, which is being developed by PhD researcher Katarzyna Okurowska, gives a better prediction of how effective the newly developed treatments are likely to be in humans.

Such data is currently obtained from expensive and highly-regulated animal research, which must precede any human clinical trials before the treatment can be made available to patients.

The availability of the model will immediately help to reduce and refine the use of animals in medical research, and may one day help to completely replace the use of animals in this kind of study.

The added advantage of the ex vivo porcine eye model is that it uses waste from the food chain.

As the eyes are a waste product, no animals are specifically bred for the study, helping to reduce the numbers of animals needed to conduct research.

Project lead, Professor Peter Monk from the University of Sheffields Department of Infection, Immunity and Cardiovascular Disease, said: Eye infections are a major cause of vision loss worldwide.

Loss of vision leads to a reduction in the quality of life and impairs the economic productivity of the individual and the nation.

There is a need for effective and affordable treatments that can prevent its occurrence, and so we established this model to enable the treatments that we and others are developing to reach the clinic rapidly.

Dr Esther Karunakaran, Co-Director of SCARAB from the University of Sheffields Department of Chemical and Biological Engineering, said: The model has been developed as part of a larger multidisciplinary project funded by the Medical Research Council Global Challenge Research Fund (MRC-GCRF), to develop a novel treatment to prevent eye infections in the developing world.

"We are also working with the LV Prasad Eye Institute in India," she said.

Fight against Coronavirus: Full coverage

Read more from the original source:
Waste from the food chain could hold the clue to treating eye infections worldwide - India TV News

Read More...

A new study on cosmonauts brains with space traveler will lead to new motor skills with slightly we … – Stanford Arts Review

Friday, September 18th, 2020

Space travel cause motor skill and impaired vision

A comparatively permanent change in the capability to perform a skill as an outcome of practice or experience is called motor learning. Showing in the performance is an act of executing a motor skill. Therefore a motor skill is a learned ability to cause a predetermined movement outcome with maximum assurance. The goal of motor skill is to optimize the ability to perform the skill at the rate of success, precision, and to reduce the energy consumption required for performance. Continuous practice of a specific motor skill will answer in greatly improved performance, but not all movements are motor skills. Motor skills are something most of us do without even thinking about them. According to Glencoe McGraw-Hill Education motor skills are related to fitness is liveliness, sense of balancing, bringing together, authority, response time, and speed. These six components include standing, walking, going up and downstairs, running, swimming, and other activities that use the large muscles of the arms, legs, and torso.

Normally, vision impairment means eye diseases such as macular degeneration, cataract and glaucoma create eye disorders which are caused because of eye injuries or birth defects. Whereas the person who travels space station will suffer from vision impairment problems. Therefore if the persons eyesight which is not been corrected to a normal level is said as impaired vision. This vision impairment may be because of loss of visual acuity which means the eye does not see objects as clearly as usual.

An astronaut or cosmonaut is a person trained by a human space flight program to command, pilot, or serve as a crew member of a spacecraft. Until 2002, astronauts were sponsored and trained exclusively by governments, either by the military or by civilian space agencies. The word cosmonaut is originally derived from Russian space travellers more over the word cosmonaut mean a sailor of the universe which is derived from the Greek word kosmos meaning universe and nautes meaning sailor. Therefore Cosmonaut Brain acquired some kind of new motor skill, like riding a bike,

A study published examined that the researcher who returned from a lengthy mission of seven months in international space station discover that the brain of eight male Russian researchers have the minor changes in the cosmonauts brain that suggested the men were more dexterous but had slightly weaker visions. The researcher used a type of MRI Magnetic resonance imaging which is a medical imaging technique used in radiology to form pictures of the anatomy and the physiological processes of the body. MRI scanners use strong magnetic fields, magnetic field gradients, and radio waves to generate images of the organs in the body where a 3D image of the cosmonauts brains is produced. The scan showed an increased amount of tissue in the cerebellum the part of the brain responsible for balance, coordination, and posture. But the scans also showed that the people living in space could wind up with trouble seeing up-close. Both of those changes could potentially be long-lasting. Thus, researchers expected to see temporary changes in the cosmonauts brains, but they were surprised to discover that the proved motor skills were still there several months after they would return to earth. Anyway, nothing on the earth is being comparative; it is possible when they go to their next mission that they can adapt more quickly. Thus it is proved that there will be a brain shift in space, which potentially resulting in blurred vision. Cosmonauts on the International Space Station typically exercise more than two hours a day to combat this process. They can also feel disoriented or motion sick while their body adjusts to a weightless environment. One important difference between life in space and on earth is that our blood and bodily fluids normally move against the downward tug of gravity, whereas in space, astronauts bodily fluids shift upwards.

Read more from the original source:
A new study on cosmonauts brains with space traveler will lead to new motor skills with slightly we ... - Stanford Arts Review

Read More...

Corneal Implants Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025 – The Research Process

Friday, September 18th, 2020

Latest updates on Corneal Implants market, a comprehensive study enumerating the latest price trends and pivotal drivers rendering a positive impact on the industry landscape. Further, the report is inclusive of the competitive terrain of this vertical in addition to the market share analysis and the contribution of the prominent contenders toward the overall industry.

Increasing demand for minimally invasive eye surgical procedures globally has positively influenced corneal implants industry growth during forecast years. Conventional treatment options for corneal diseases have proven to be risky due to complexity involved. To cater to this problem, researchers have developed innovative techniques that involves placing of donor tissue from second layer of cornea. Newly introduced techniques of corneal implants strengthened and flattened the cornea thereby, improving eye sight of the patients suffering from keratoconus. As recently manufactured artificial corneal implants are utilized in these minimally invasive procedures, the corneal implants industry will offer numerous growth opportunities.

Growing elderly population base in developed economies is one of the major factors driving industry growth as majority of them suffer from eye disorders. According to National Eye Institute, around 2.1 million elderly Americans have age-related macular degeneration. In countries such as the U.S. and Germany, geriatric population suffering from diabetes has high prevalence of diabetic retinopathy. This scenario proves beneficial for corneal implants market growth as it substantially augments demand of corneal implants. However, shortage of human donor material will affect the industry growth to some extent in coming years.

Request Sample Copy of this Report @ https://www.theresearchprocess.com/request-sample/5997

Corneal Implants Market will exceed USD 500 million by 2025; as per a new research report.

Request Sample Copy of this Report @ https://www.theresearchprocess.com/request-sample/5997

Penetrating keratoplasty segment accounted for 47% in 2018. Demand for penetrating keratoplasty is projected to grow gradually in the near future. This procedure is completed in one or two hours and performed on outpatient basis. Thus, patients are able to resume to daily activities in few hours. As recovery time is less its demand is expected to grow over forecast period. Also, plastic shield utilized in these procedures protects eye and enhances healing process that further propels its demand.

Keratoconus segment is projected to have more than 6% growth during analysis timeframe. This condition is predicted to damage cornea and affect vision. Mostly, the patients suffering from keratoconus disease experience distortion of vision causing obstruction in performing daily tasks. This raises the demand for corneal transplant procedures thereby, positively impacting the segmental growth in forthcoming years.

Artificial corneal implants segment witnessed around 10% CAGR throughout the analysis period. Recently developed artificial corneal implants are considered as a substitute for patients that cannot tolerate human donor cornea. According to Cornea Research Foundation of America, around 10 million people suffer from corneal blindness globally out of which only 100,000 corneal implant procedures get access to human donor tissue. Thus, crisis of human donor tissue has boosted the demand for artificial corneal implants, thereby escalating the segment growth.

Eye clinics segment was valued over USD 49 million in 2018 and is projected to have significant growth throughout the analysis timeframe. Eye clinics have expertise that help in diagnosing the eye disease. However, some of these clinics are not self-sufficient to perform surgeries and non-invasive transplant procedures due to budget constraints. Physicians and eye specialists working at eye clinics refer patients to hospitals that are well-equipped and perform surgical procedures.

Major Highlights from Table of contents are listed below for quick lookup into Corneal Implants Market report

Chapter 1. Competitive Landscape

Chapter 2. Company Profiles

Chapter 3. Methodology & Scope

Chapter 4. Executive Summary

Chapter 5. Corneal Implants industryInsights

Request Customization on This Report @ https://www.theresearchprocess.com/request-for-customization/5997

See the original post:
Corneal Implants Market Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025 - The Research Process

Read More...

Eyesight Test Equipment Market Analysis And Demand With Forecast Overview To 20 – News by aeresearch

Friday, September 18th, 2020

The Eyesight Test Equipment Marketanalysis summary is a thorough study of the current trends leading to this vertical trend in various regions. Research summarizes important details related to market share, market size, applications, statistics and sales. In addition, this study emphasizes thorough competition analysis on market prospects, especially growth strategies that market experts claim.

The latest report is prepared keeping in mind the current COVID-19 pandemic, which has severely affected various market segments regionally and globally. The report includes a comprehensive market study based on the post-COVID-19 market scenario for the market. The report not only describes the current and future effects of the pandemic on the global market, but also highlights the more effective products and services which have been developed by the industry participants and thus form the basis of the competitive landscape of the market.

Eyesight Test Equipment Market Competitive Analysis:

Request Sample Copy of this Report @ https://www.aeresearch.net/request-sample/302167

The report provides a comprehensive analysis of the major market players in the market along with their business overview, expansion plans, and strategies. The main players examined in the report are:

The global Eyesight Test Equipment market has been segmented on the basis of technology, product type, application, distribution channel, end-user, and industry vertical, along with the geography, delivering valuable insights.

Type Coverage in the Market are:Portable andStationary

Market Segment by Applications, covers:Children,Adults andThe older

Global Eyesight Test Equipment Market: Regional Segments

The chapter on regional segmentation details the regional aspects of the global Eyesight Test Equipment market. This chapter explains the regulatory framework that is likely to impact the overall market. It highlights the political scenario in the market and the anticipates its influence on the global Eyesight Test Equipment market.

Major factors covered in the report:

Report Overview:It includes six chapters, viz. research scope, major manufacturers covered, market segments by type, Eyesight Test Equipment market segments by application, study objectives, and years considered.

Global Growth Trends:There are three chapters included in this section, i.e. industry trends, the growth rate of key producers, and production analysis.

Eyesight Test Equipment Market Share by Manufacturer:Here, production, revenue, and price analysis by the manufacturer are included along with other chapters such as expansion plans and merger and acquisition, products offered by key manufacturers, and areas served and headquarters distribution.

Market Size by Type:It includes analysis of price, production value market share, and production market share by type.

Market Size by Application:This section includes Eyesight Test Equipment market consumption analysis by application.

Profiles of Manufacturers:Here, leading players of the global Eyesight Test Equipment market are studied based on sales area, key products, gross margin, revenue, price, and production.

Eyesight Test Equipment Market Value Chain and Sales Channel Analysis:It includes customer, distributor, Eyesight Test Equipment market value chain, and sales channel analysis.

Market Forecast Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

The analysis objectives of the report are:

Request Customization on This Report @ https://www.aeresearch.net/request-for-customization/302167

Here is the original post:
Eyesight Test Equipment Market Analysis And Demand With Forecast Overview To 20 - News by aeresearch

Read More...

What does restoring a person’s sight and an accountant have in common? – Stuff.co.nz

Friday, September 18th, 2020

The good work done on a daily basis by The Fred Hollows Foundation NZ is celebrated throughout the Pacific.

But what is less well-known is the cutting-edge financial and operational strategies in place within the organisation, facilitated by a chartered accountant with the knowledge and expertise needed to ensure the charity's ongoing success.

Visionary work to restore eyesight

Aregistered charity that carries on the work of famous Kiwi eye surgeon Professor Fred Hollows and his vision to end avoidable blindness, The Foundation's chairman Craig Fisher FCA, says their mission remains vital.

"Tragically four out of five people who are blind in the developing world don't need to be, and this can be addressed often with cataract surgery and if there is access to trained doctors and nurses,"he says. "The New Zealand Foundation exists to address this issue in the Pacific."

SUPPLIED

Jessie Napong, (pictured middle) is a patient of the Fred Hollows outreach clinic, Port Vila, Vanuatu.

Business strategies vital to governance

Fisher, a Chartered Accountant, was asked to join the governance team of The Foundation nine years ago - at a time when they had "less experienced in-house accounting capacity."

"While some good hard working well-meaning people had been employed, they were not of the level of an experienced chartered accountant.

"The appeal of me joining was my knowledge of financial and other systems," Fisher says.

Chartered accountants are well trained and experienced in financial systems, and are able to provide input that ensures appropriate strategies are put in place to significantly assist the organisations they work with.

Transforming for a digital era

Fisher says that a large part of his role as chairman has been to progressively improve the professionalism, effectiveness and impact of the organisation.

To this end, he identified the need for an experiencedchartered accountant to help bring the organisation into the digital age, and up-to-speed with the changing regulatory environment, which demanded much more accountability from the not-for-profit sector.

Enter Sharon Orr. A Chartered Accountant with many years' experience in senior finance roles in the commercial sector. Whilst she had not worked for a not-for-profit before coming on board as finance andoperations director in early 2017, she quickly made her mark at The Foundation by incorporating many of the protocols and disciplines adopted in a commercial environment.

She says "I realised early on that while many charities focussed on minimising administration costs, it often came at the expense of under-resourcing their finance teams who were charged with ensuring the charity met the vast array of compliance, regulatory and statutory reporting requirements. In the case of The Foundation, these spanned multiple countries with complex and often confusing taxation systems."

One of the more challenging achievements was meeting the Payment Card Industry (PCI) compliance requirements as the standards dictated that the thousands of credit card details processed by The Foundation, had to meet the strict processing standards and privacy requirements.

"Charities such as The Foundation, who operate across multiple countries also have the added complexity of managing their foreign currency exposure especially when dealing in volatile currencies. Often significant grant funding is received from overseas institutional donors in foreign currencies and the finance team is tasked with managing the foreign currency risk."

SUPPLIED

Sharon Orr CA is the acting chief executive of The Fred Hollows Foundation NZ, she is also a Chartered Accountant with many years' experience in senior finance roles.

Instilling confidence in donation allocation

One of Orr's systemic changes was putting in placesystems that provided for integrated reporting of financial and non-financial information.

"Key considerations for all donors are the ability to see where their donations have been spent, the impact that the charity has made in meeting its vision and that the utilisation of donor funding is maximised. Charities must also have appropriate forecasting systems to manage cash flows and ensure that future revenues will be sufficient to meet forecasted expenditure on programme activity."

Chartered accountants offer a big picture approach

With Orr's appointment, the operational and financial arms of the organisation were brought together, allowing for a "big picture" approach that would take in the entire organisation.

"I found travelling to our managed clinics, in the Solomon Islands, Papua New Guinea and Fiji, gave me a real sense of the issues and challenges faced by our in-country finance teams. It armed me with the information I needed to be able to support and guide them to success with issues such as achieving a smooth audit process, strengthening internal controls and implementing cloud based digital platforms," says Orr.

Andrew Bell, former CEO for The Fred Hollows Foundation NZ, says that he wasn't aware that chartered accountants could work across both sides of an organisation so effectively; and that Orr's depth of knowledge allowed her to tackle multiple issues facing the charity.

"There have been significant changes to the Charities Act, which meant we had to undertake the same level of reporting as a company. Alongside this, there has been a rise in cybercrime, particularly targeting charities; and we needed to use our digital accounting software more efficiently."

SUPPLIED

The Fred Hollows Foundation NZ operate across multiple countries also have the added complexity of managing their foreign currency exposure.

Improving security through tech changes

Bell says Orr led from the front; maximising the efficiency of the accounting system (Xero), ensuring the organisation's digital components were ironclad and safe from external threats; helping train and mentor more junior staff (giving them more responsibility and freeing up her time), and shoring accounting and privacy issues ahead of regulatory changes.

"This is the level of trust the board has in her abilities," he says. "As a chartered accountant, she's part of a breed of finance professionalsshe's active, up front, and everyone knows who she is."

Fisher agrees"She has helped our organisation to be more resilient and sustainable, which are two key drivers for me in my governance. "[Very quickly] she became a key member of our senior leadership team and her thoughtful methodological accountant's approach is greatly appreciated by others here."

To see how a CA can make a difference to your business, or to find one in your area visit http://www.cadifferencemakers.com.

See the rest here:
What does restoring a person's sight and an accountant have in common? - Stuff.co.nz

Read More...

The end-use Industries to Help the Tooth Regenerations market stand in a good stead between 2018 and 2026 – The Daily Chronicle

Friday, September 18th, 2020

The tooth is a biological organ and consists of multiple tissues including the cementum, dentin, enamel, and pulp. Dental caries, Periodontal disease, and tooth fracture are the three main factor for tooth loss. Tooth Regeneration is the specialty concerned with the treatment of dental diseases such as a cavity, periodontal disease and fracture of the tooth. Dental caries is also known as tooth decay is the main oral health problems in most of the industrialized countries. Facial trauma also the major cause of tooth loss. Tooth loss leads to people mentally and physically disturb and it also affect the self-confidence and quality of life. Tooth regeneration is the process of individual tissue and the whole tooth development. Basically, it is the process of restoring the loss of natural teeth. Tooth regeneration is stem cell-based regenerative medical procedure which is used in stem cell biology sector and tissue engineering. There are two approaches used in the build of new whole teeth, in vivo implantation of tooth germ cells which were previously generated from stem cells and grow in vitro cells and another organotypic culture is an appropriate technique for the generation of teeth. The process of tooth regeneration imitates the natural tooth development using stem cells. In another way instead of whole teeth regeneration, Different part of the teeth regenerates such as Enamel regeneration, Dentin regeneration, Pulp regeneration, and periodontal regeneration.

Globally increasing incidence and prevalence of dental problems such as a cavity, periodontal disease, and tooth fracture are the major factors driving the growth of the Tooth Regenerations market. Innovative new techniques in Tooth regeneration such as cell homing, cell transplantation is expected to increase the acceptance of Tooth Regenerations. Tooth regeneration not only regrowth the entire tooth but also the restoration of individual components of the tooth such as dentin, cementum, enamel and dental pulp and these individual regeneration process is anticipate the boost the market growth of tooth regeneration market. Dental implantation also increases the growth of tooth regeneration market. People are very keen interested in the tooth regeneration and they are also giving more importance to the aesthetic aspects of dental products, which is expected to increase the Tooth Regenerations and dental market over the forecast period. The increasing demand for a customized Tooth Regeneration with the specifications and other dental decorative installations is the key factor anticipated to propel the demand for Tooth Regenerations worldwide.

To remain ahead of your competitors, request for a sample [emailprotected]

https://www.persistencemarketresearch.com/samples/26263

The Global Tooth Regenerations market is segmented on the basis of application, Demographics, technique and by End user

Based on the Application type Tooth Regenerations market is segmented as:

Based on the Demographic Tooth Regenerations market is segmented as:

Based on the Technique, Tooth Regenerations market is segmented as:

Based on the end user Tooth Regenerations market is segmented as:

According to WHO, approx.30% the geriatric population is affected by the complete loss of teeth. Rapidly increasing Dental cavities and periodontal diseases are the major drivers in the Tooth Regenerations market. The global Tooth Regenerations market by application is expected to be dominated the market of Tooth Regenerations, out of which Enamel segment is expected to generate maximum revenue share over the forecast period. By end user, Tooth Regenerations market is expected to be dominated by dental clinics and hospitals. The manufacturers in the concerned market are focusing on manufacturing advanced products for better patient compliance and make the procedure easier. The market of tooth regeneration is anticipated to boost by stem cell regeneration technology

To receive extensive list of important regions, Request Methodology here @

https://www.persistencemarketresearch.com/methodology/26263

The global Tooth Regenerations market is expected to be dominated by North America due to higher adoption and significant geriatrics population which also increase the demand for dental service for Dental caries and Periodontal disease. Europe is expected to be the second most lucrative Tooth Regenerations market due to rising funds for research for the growing patient population. Asia-Pacific is expected to be the fastest growing Tooth Regenerations market due to rapidly increasing incidence of dental surgery, general prosthetic fixation. Latin America and Middle East & Africa are expected to be the least lucrative market due to Low awareness regarding the use of Tooth Regenerations technology and comparatively less developed healthcare infrastructure in major regions.

Examples of some of the market participants in the global Tooth Regenerations market identified are DENTSPLY Implant, Unilever, Datum Dental, Institut Straumann AG, Keystone Dental, Inc., Zimmer Biomet, Wright Medical Group N.V., Integra LifeSciences, CryoLife, Inc, BioMimetic Therapeutics, Inc, Cook Group and among others.

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

You Can Request for TOC Here @https://www.persistencemarketresearch.com/toc/26263

Explore Extensive Coverage of PMR`s

Life Sciences & Transformational HealthLandscape

About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics andmarket research methodologyto help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMRs collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Naved BegPersistence Market ResearchAddress 305 Broadway, 7th Floor, New York City,NY 10007 United StatesU.S. Ph. +1-646-568-7751USA-Canada Toll-free +1 800-961-0353Sales[emailprotected]Websitehttps://www.persistencemarketresearch.com

Go here to see the original:
The end-use Industries to Help the Tooth Regenerations market stand in a good stead between 2018 and 2026 - The Daily Chronicle

Read More...

The Wright Medicine: Getting to the ‘heart’ of the matter – Valley Advantage

Friday, September 18th, 2020

I have a warm heart for our community. As a NEPA native, Im inspired by the ways The Wright Centers for Community Health and Graduate Medical Education and our larger community have navigated together this unprecedented and very challenging time of uncertainty caused by the COVID-19 pandemic. As a longtime, passionate primary care provider and medical educator, I am especially proud to be witnessing and experiencing the very best of what Ive always known about the noble profession of medicine: that the people maintaining the front lines of health care delivery do so for all the right reasons, striving to serve humanity with an abundance of courage, care and compassion, especially for the most vulnerable among us.

With World Heart Day coming up on Sept. 29, its important to acknowledge that although we dont know what the ongoing public health crisis still has in store for us, there is no doubt that taking care of ourselves and each other and promoting cardiovascular health are just as important as ever.

According to the World Heart Federation, cardiovascular disease is the No. 1 cause of death on our planet, and its primary causes are all too familiar to our regional community: smoking, diabetes, high blood pressure, sedentary lifestyles and obesity. Heart failure which happens when the heart fails to pump enough blood to the body and brain, resulting in symptoms like breathlessness, fatigue and swollen limbs affects 26 million worldwide and it is the top cause of hospitalization. Most concerning at this time is that people with underlying conditions, such as diabetes and heart disease, are most vulnerable to complications and death from COVID-19.

And yet one of the most troubling trends during the pandemic has been that many patients, including those with cardiovascular issues, have been avoiding routine medical care, preventative immunizations and even foregoing emergency room visits for fear of contracting the novel coronavirus within our healthcare systems.

Its absolutely critical that we tackle the double-edged threats cardiovascular disease and COVID-19 pose through raising awareness and promoting prevention and early detection, while offering reassurance. As everyone remains vigilant about staying safe and slowing transmission of the virus by wearing face masks, washing their hands frequently and continuing social distancing, I want to make sure the message is loud and clear that your primary care and specialty doctors offices and hospital emergency rooms are safe.

Please keep your health care on track, including timely acute and chronic disease management visits and also vaccination and cancer screening prevention services. The risks of undertreated hypertension and diabetes and untreated heart attacks and stroke far outweigh the risks of contacting COVID-19. And in times of cardiovascular troubles like heart attacks or strokes, every second counts.

The biggest keys to fighting cardiovascular disease education and prevention through healthy lifestyle behaviors are at the heart of two major Wright Center innovations aimed at enhancing the quality of and lengthening the lives of people in NEPA and across the country.

One is relatively brand new. Our Lifestyle Medicine initiative launched this summer as both a focused field of study for our resident doctors and fellows, as well as a key component of our patient-centered care for all routine clinical visits.

The other initiative is celebrating its 10th anniversary: our pioneering Cardiovascular Disease Fellowship, which launched in response to NEPAs well-documented cardiovascular health needs under the leadership of Dr. Samir Pancholy, with support from Geisinger, the Wilkes-Barre Veterans Affairs Medical Center and Commonwealth Health System.

Lifestyle Medicine encourages prevention by empowering patients to make better choices. We can look after our hearts and help to prevent cardiovascular disease by eating a healthy diet, saying no to tobacco and other risky substances, and getting plenty of sleep and exercise.

Our Cardiology Fellowship, meanwhile, trains doctors in community-based and hospital settings throughout Lackawanna and Luzerne counties. Over the course of their years in the program, fellows train one-on-one with our globally and nationally recognized, NEPA-based, board-certified cardiologists and cardiothoracic surgeons. Under our distinguished facultys guidance and on rotations through cardiac consultations, cardiac care units, cardiac catheterization and cardiovascular surgeries, our fellows acquire the knowledge and skills needed to provide state-of-the-art cardiac care, all while advancing our regional healthcare delivery system through their research projects and system improvement efforts.

The last decade of our Cardiology fellowship has produced a number of cardiac specialists who have stayed in NEPA to serve our community and to make meaningful contributions to our regions comprehensive care opportunities.

Celebrate World Heart Day by paying worthy attention to your self care and optimizing your cardiovascular health. Learn more about Lifestyle Medicine and the Million Hearts National Campaign. Most importantly, when you need help, reach out to your doctor and stay connected to other resources within our local health care community.

Linda Thomas-Hemak, M.D., a primary care physician triple board-certified in pediatrics, internal medicine and addiction medicine, leads The Wright Center for Community Health as CEO and serves as President of The Wright Center for Graduate Medical Education. She lives with her family and practices primary care in Jermyn. Send your medical questions to news@thewrightcenter.org.

See the original post here:
The Wright Medicine: Getting to the 'heart' of the matter - Valley Advantage

Read More...

Researchers discover antibody molecule that could be used as preventative to COVID-19 – One America News Network

Friday, September 18th, 2020

A monitor depicts the structure of SARS-CoV-2 during a Senate Health, Education, Labor and Pensions Committee hearing to discuss vaccines and protecting public health during the coronavirus pandemic on Capitol Hill, Wednesday, Sept. 9, 2020, in Washington. (Michael Reynolds/Pool via AP)

Researchers at the University of Pittsburgh School of Medicine said they have isolated a molecule that could be used as a treatment against COVID-19.

According to a report released earlier this week, the scientists isolated the smallest biological molecule that specifically neutralizes the virus that causes the virus.

The molecule has been used to create the drug Ab8 and has been viewed as a potential preventative treatment. Head researchers said the molecule is 10 times smaller than a regular sized antibody, which means it can penetrate into more areas of the body.

Its fully human, meaning that theres no foreign material thats likely to be rejected by the host, explained Dr. John Mellors, Division of Infectious Diseases at the University of Pittsburgh. Its extremely potent.

The molecule also doesnt bind to human cells, which suggests there would be no negative side effects. Researchers are also looking into different ways to administer the treatment and said it could be inhaled rather than injected.

Read more from the original source:
Researchers discover antibody molecule that could be used as preventative to COVID-19 - One America News Network

Read More...

With addiction and suicide on the rise, we must increase access to mental health care – Courier Journal

Friday, September 18th, 2020

Rachel Roberts, Opinion contributor Published 6:16 a.m. ET Sept. 18, 2020

The rise of COVID-19 has understandably refocused our attention on health care access and inequities.One component that hasnt gotten as much attention, but should, is access to mental health care.Were in a moment where more of us than ever before could benefit from having an established relationship with a qualified provider.

Although we have seen sustained success in the fields of mental health care, counseling and addiction services in recent decades from gains in medicine to a more aware and understanding publicthe statistics are clear that this is not enough.

Indeed, two of the main drivers behind reports showing life expectancy is declining in the United States are the rising rates of drug addiction and suicide.The public has a good understanding of the importance of addressing the former, but comparatively less attention is given to how to spot and then stop someone from taking his or her life.

Related:Inequity in mental health care is yet another challenge facing the minority community

To understand suicides sizable scope, consider that its number here in the United States is four times higher than those murdered and a third larger than those killed in traffic accidents.Suicide rates are highest among adults between 45 and 64, and those with substance abuse disorders are six times more likely to commit suicide than those without, according toMental Health America.Worldwide, there are 800,000 suicides a year, or an average of one every 40 seconds.

I learned from an early age how much of a difference it makes when someone in crisis gets the care they need.My dad worked as an addiction specialist and had his office on the ground floor of our home.There were many times that I saw him open the door for clients who were struggling to survive, and there is no telling how many lives he and his friends in the field saved.

I will never forget the example he set, and it is one of the reasons why I proudly serve as a board member for Mental Health America of Kentucky andwhy improving access to mental healthand addictionservices across Kentucky is so important to me as a state legislator.

To further that goal, I am sponsoring legislation that would make what I think is a long-overdue change.I chose toannounceit Sept.10 to coincide with World Suicide Prevention Day and Suicide Prevention Awareness Month for our country.

Kentucky Rep. Rachel Roberts, a Democrat,represents District 67.(Photo: provided)

In short, my bill calls for comprehensive health insurance plans to include anannual preventative mental health checkup.

Just as we understand the importance of monitoring blood pressure and cholesterol and regularly visiting the dentist and eye doctor,we shouldcheck on our mental health in the same way.

If we want toprioritize mental health and well-being for all Kentuckians, were going to have to do more than we have done.There may be no single answer to get us to that destination, but my bill undoubtedly would move us in the right direction.

If you or someone you know is at risk of committing suicide, please do not hesitate to act.The National Suicide Prevention Lifeline is available 24 hours a day and can be reached at 800-273-8255.If it is an immediate emergency, please call 911.

Rachel Roberts, a Democrat,is a Kentucky representative forDistrict 67.

Read or Share this story: https://www.courier-journal.com/story/opinion/2020/09/18/kentucky-bill-would-help-increase-access-to-mental-health-care/5786847002/

Read more here:
With addiction and suicide on the rise, we must increase access to mental health care - Courier Journal

Read More...

FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C) – PRNewswire

Friday, September 18th, 2020

NEW YORK, Sept. 16, 2020 /PRNewswire/ --The Cura Foundation in collaboration with The Marcus Foundation, Sanford Health and Alliance for Cell Therapy Now, is supporting a clinical trial of human cord tissue mesenchymal stromal cells (hCT-MSC) to treat children with Multisystem Inflammatory Syndrome in Children (MIS-C). The trial is being led by Dr. Joanne Kurtzberg at Duke University to determine if infusions of hCT-MSCs are safe and can suppress the hyper-inflammatory response and positively impact the symptom course and duration, as well as the long-term effects of this life-threatening syndrome. The hCT-MSCs are manufactured in the Robertson GMP Cell Manufacturing Laboratory at Duke. The U.S. Food and Drug Administration (FDA) approved the Investigational New Drug (IND) Application, and Dr. Kurtzberg will proceed with a multi-site pilot study later this month.

As the school year is underway more children are being diagnosed with the SARS-CoV-2 virus. According to the American Academy of Pediatrics (AAP), the cumulative number of coronavirus cases diagnosed in children has more than tripled between July 2 and September 3 from 165,845 to 513,415. As of September 3rd, children represent at least 9.8% of diagnosed cases in the U.S. and in states such as Alaska, Minnesota, Tennessee, South Carolina, New Mexico and Wyoming, children account for more than 15 percent of total cases. Some of these children have developed very serious disease. The Centers for Disease Control and Prevention reported that as of September 3rd at least 792 children in 42 states have been diagnosed with Multisystem Inflammatory Syndrome in Children (MIS-C) and 16 have died.

The Principal Investigator of the study, Joanne Kurtzberg, MD, is the Jerome Harris Distinguished Professor of Pediatrics; Professor of Pathology; Director, Marcus Center for Cellular Cures; Director, Pediatric Blood and Marrow Transplant Program; Director, Carolinas Cord Blood Bank; Co-Director, Stem Cell Transplant Laboratory at Duke University School of Medicine/Duke Health and a leader in transplantation, cell therapy, and regenerative medicine in children. Clinical sites include Duke University (Durham, NC), Children's Healthcare of Atlanta (Atlanta, GA), New York Medical College (Valhalla, NY), and others as cases occur.

"We hope this is just the beginning of our ability to support the development of cell therapies to treat COVID-19 Related Multisystem Inflammatory Syndrome in Children," said Dr. Robin Smith,president of the Cura Foundation. "As students across the country return to in-class instruction, it is more important now than ever to ensure we are equipped with potential treatment options to care for children who develop this serious disease."

About the Sponsors

The Cura Foundationleads a global health movement with the goal to improve human health. Cura unites public and private sectors, partnering with doctors, patients, business leaders, philanthropists and thought leaders to create a collaborative network that tackles major health issues and accelerates funding to advance innovations in medicine. Cura believes that by encouraging interdisciplinary approaches to medicine, promoting preventative measures and advancing the development of breakthrough medical technologies you can improve access to care, streamline health care delivery and eliminate social disparities in health care. The Cura Foundation is a nonsectarian, nonpartisan, public and tax-exempt organization under Section 501(c)(3) of the Internal Revenue Code. For more information, please visit: https://thecurafoundation.org/

The Marcus Foundationwas founded in 1989 by Bernie Marcus, co-founder and former CEO of The Home Depot, to support programs in Children and Youth Development, Community, Free Enterprise, National Security, Veterans, Jewish Causes, Healthcare and Medical Research.

Sanford Health, one of the largest health systems in the United States, is dedicated to the integrated delivery of health care, genomic medicine, senior care and services, global clinics, research and affordable insurance. Headquartered in Sioux Falls, South Dakota, the organization includes 46 hospitals, 1,400 physicians and more than 200 Good Samaritan Society senior care locations in 26 states and 10 countries. Learn more about Sanford Health's transformative work to improve the human condition at sanfordhealth.orgor Sanford Health News.

Duke Healthconceptually integrates the Duke University School of Medicine, Duke-NUS Medical School, Duke University School of Nursing, Duke University Health System, Private Diagnostic Clinic (Duke physicians practice), and incorporates the health and health research programs within the Duke Global Health Institute as well as those in schools and centers across Duke University, including the Duke-Robert J. Margolis Center for Health Policy.

Duke Health is committed to conducting innovative basic and clinical research, rapidly translating breakthrough discoveries to patient care and population health, providing a unique educational experience to future clinical and scientific leaders, improving the health of populations, and actively seeking policy and intervention-based solutions to complex global health challenges. Underlying these ambitions is a belief that Duke Health is a destination for outstanding people and a dedication to continually explore new ways to help our people grow, collaborate and succeed.

Alliance for Cell Therapy Now(ACT Now) is an independent, non-profit organization devoted to advancing the availability of and access to safe and effective cell therapies for patients in need. ACT Now convenes experts and stakeholders to develop and advance sound policies that will improve the development, manufacturing, delivery, and improvement of regenerative cell therapies. Seehttp://allianceforcelltherapynow.org/

Contact

The Cura FoundationRobin Smith, MD, +1-212-584-4176[emailprotected]

SOURCE Alliance for Cell Therapy Now

allianceforcelltherapynow.org

More:
FDA Approves Study to Investigate the Use of Cell Therapy to Treat COVID-19 Related Multisystem Inflammatory Syndrome in Children (MIS-C) - PRNewswire

Read More...

Dekalb County town hall will provide information about flu and COVID-19 – Decaturish.com

Friday, September 18th, 2020

Decatur, GA DeKalb County Commissioner Lorraine Cochran-Johnson is partnering with Kaiser Permanente to host a special countywide town hall to share important information on how to stay healthy through the COVID-19 pandemic and upcoming influenza season, according to a press release from the county.

The Flu in an Era of COVID-19 Town Hall will take place Wednesday, Sept. 23, 2020, at 6 p.m. and will feature medical doctors that specialize in population health.

According the Centers for Disease Control and Prevention, there is a high probability that the flu and COVID-19 viruses will begin increasing in October and will spread this fall and winter. Commissioner Cochran-Johnson feels now is the time stress the importance of coupling education with preventative measures to avoid contracting both.

It is vital that we continue to stay steadfast in our efforts to decrease and ultimately stop the spread of COVID- 19, said Commissioner Cochran-Johnson. With flu season approaching, we must be equally intentional in educating the public on what to expect and how to stay healthy in the midst of this pandemic.

The Flu in an Era of COVID-19 Town Hall will educate DeKalb residents on the differences between the flu and COVID-19 and how they can affect each other, according to the press release from the county. In addition, residents will learn from medical experts how the flu and COVID-19 can impact ones mental and physical health, including pregnancies.

Presentations will be made by Dr. Chris Griffith (child, adolescent & adult psychiatrist & obesity medicine at Kaiser Permanente), Dr. Fatu Forna (physician program director for perinatal safety and quality at Kaiser Permanente), Dr. Belkis Pimentel (physician program director, quality performance and population health and flu expert at Kaiser Permanente) and Dr. Lynette Wilson-Phillips (pediatrician and co-medical director for Kids-Doc on Wheels).

COVID-19 and influenza are both respiratory illnesses that are contagious and have similar symptoms, however they are caused by different viruses and neither should be taken lightly, said Dr. Chris Griffith. Kaiser Permanente and its staff of medical professionals understand this and are dedicated to educating the public on the facts and how to stay healthy.

Decaturish.com is working to keep your community informed about coronavirus, also known as COVID-19. All of our coverage on this topic can be found at Decaturishscrubs.com. If you appreciate our work on this story, please become a paying supporter. For as little as $3 a month, you can help us keep you in the loop about what your community is doing to stop the spread of COVID-19. To become a supporter, click here.

Want Decaturish delivered to your inbox every day? Sign up for our free newsletter by clicking here.

See the rest here:
Dekalb County town hall will provide information about flu and COVID-19 - Decaturish.com

Read More...

Physician Quality Partners generated $9.7 million in savings while improving care quality [Free read] – Port City Daily

Friday, September 18th, 2020

Demonstrating what is possible when working together to deliver higher quality care at lower costs, New Hanover Regional Medical Centers Medicare Shared Savings Program Accountable Care Organization (ACO), Physician Quality Partners (PQP), earned top scores in the latest data released by the Centers for Medicare & Medicaid Services (CMS).

PQP improved care for almost 20,000 Medicare beneficiaries in New Hanover and the surrounding counties, saving Medicare over $9.7 million by meeting quality and cost goals in 2019, according to recently released performance data from CMS, the federal agency that administers Medicare. PQP reduced the average cost of care by $501 per beneficiary.

PQP earned a quality score of 98.75 percent on performance measures ranging from preventive health checks, to use of electronic health records, to preventing avoidable hospitalizations, according to Medicare data.

Our work to improve care and quality while lowering costs within this group is just the beginning of what we can do to improve our regions health, said NHRMC President and CEO John Gizdic. By growing in our ability to provide new care options and access data that can be used to identify ways to improve care, we can help more people and lower overall costs.

The $9.7 million of gross savings to Medicare that PQP generated also resulted in a shared savings payment of $4.4 million to PQP, which will be used to help fund further investments in quality improvement and care management support to improve our beneficiaries health outcomes.

Partnering with our ACO providers is foundational in better serving patients, driving outcomes, and delivering value in this complex healthcare landscape, said Leelee Thames, MD, MBA, NHRMCs Chief Value Officer and ACO Medical Director. ACOs like ours are not only driving down costs, but most importantly, making remarkable improvements in the health and quality of life of our beneficiaries.

For example, PQP providers strive to improve long-term outcomes by directing efforts to services like annual wellness visits and evidence-based preventative screenings, known to impact disease conditions. The ACO also focuses on ensuring care is coordinated to ensure smooth transitions from the hospital to home or a nursing home if needed. All ACO providers receive detailed information about their performance on quality measures, and clinicians and providers share best practices to coordinate the care beneficiaries receive to prevent complications and repeat hospitalizations.

Through these efforts to improve outcomes, PQPs hospital admission rates dropped 17% and ED rates dropped 6.3% since the programs inception in 2016. Over the last year alone, PQP reduced unnecessary admissions and readmissions by over 2%, and Emergency Department visit rates by over 3%.

ACOs empower local physicians, hospitals and other providers to work together and take responsibility for improving quality, enhancing patient experience and keeping care affordable. The Medicare Shared Savings Program (Shared Savings Program) creates incentives for ACOs to invest in transforming care by allowing them to share in savings they generate after meeting defined quality and cost goals.

According to CMS, 541 Shared Savings Program participants generated $1.19 billion in total net savings to Medicare in 2019. ACOs continued to show improved or comparable quality performance on measures compared to other physician group practices.

The Medicare ACO shared savings program is the largest value-based payment model in the country and a critical tool in moving the health system toward higher value, said Lydia Newman, PQPs Executive Director.

PQP is a collaborative that includes the NHRMC Physician Group and Intracoastal Internal Medicine, an independent practice in Wilmington.

Founded in 2013, Physician Quality Partners (PQP) was created by New Hanover Regional Medical Center. The participating providers are united with the common goal of helping beneficiaries receive the right care, at the right time, in the right setting. In 2016, PQP began participating as a Tack 1 ACO in the Shared Savings Program and renewed participation on July 1, 2019 in the new Pathways to Success Model as a Track B participant.

To learn more about Physician Quality Partners, call 910-667-7640 or visit http://www.physicianqualitypartners.com.

You also can call 1-800-MEDICARE (1-800-633-4227), TTY users should call 1-877-486-2048 and tell the representative youre calling to learn more about ACOs or visit Medicare.gov/acos.html.

Sponsored content by

Read more here:
Physician Quality Partners generated $9.7 million in savings while improving care quality [Free read] - Port City Daily

Read More...

UK research getting to bottom of COVID clots – ABC 36 News – WTVQ

Friday, September 18th, 2020

The research led by Jeremy Wood, Zach Porterfield and Jamie Sturgill in the Department of Internal Medicine; Beth Garvy in Microbiology, Immunology & Molecular Genetics; and Wally Whiteheart in Molecular & Cellular Biochemistry, suggests localized inflammation in the lungs caused by COVID-19 may be responsible for the increased presence of blood clots in patients.

The study also provides evidence suggesting the risk of thrombosis could persist after the infection clears.

The study examined the blood of 30 COVID-19 patients including 15 who were inpatients in the intensive care unit, and 15 who received care as outpatients at UKs Infectious Diseases Clinic, along with eight disease-free volunteers who acted as a control group.

Compared to baseline, the COVID-19 patients had elevated levels of tissue factor, a protein found in blood that initiates the clotting process. Patients also had reduced levels of protein S, an anticoagulant that helps prevent blood clotting.

The researchers concluded that lung inflammation caused by COVID-19 is what leads to a decrease in protein S. Thisinflammation also causes immune and possible endothelial cell activation, which leads to increased tissue factor protein.

What weve learned is that the clotting is not caused by anything systemic. Localized inflammation in the lungs is whats driving this whole process, Wood said. With an increase in tissue factor and a deficiency in protein S, COVID-19 patients get more blood clotting without the ability to shut it down or control it.

The study additionally showed that protein S levels remained low in some patients even after they tested negative for COVID-19, which suggests that blood clotting issues may persist after infection and long-term monitoring of thrombotic risk may be necessary.

Wood says this preliminary data could be a cause for concern. Certain viruses like HIV are linked to a long-term deficiency in protein S, which causes an ongoing risk of thrombosis in patients. It is not yet known if COVID-19 could cause a similar persisting protein S deficiency.

Tissue factor and protein S are good markers to monitor for long-term thrombosis risk and the data suggest that we need to be monitoring these patients because were not seeing these parameters corrected immediately, Wood said.

The research team recently received a grant from UKsCenter for Clinical and Translational Science(CCTS) to begin a longitudinal study to look at these levels in patients over the next year.

This will help answer the question: will this risk remain like it is in the HIV patients or will it go away?

The study was funded in part by anAlliance Grantthrough the College of Medicine as well as UKsCOVID-19 Unified Research Experts (CURE) Alliancethroughthe Vice President for Research and the College of Medicine and the CCTS. It was a product of collaboration between a number of different groups at UK that have been studying COVID-19.

Additional collaborators includeMartha Sim, Meenakshi Banerjee and Hammodah Alfar in the Department of Molecular and Cellular Biochemistry; Melissa Hollifield and Jerry Woodward with Microbiology, Immunology and Molecular Genetics; Xian Li with the Saha Cardiovascular Research Center; Alice Thornton with the Division of Infectious Disease; and Gail Sievert, Marietta Barton-Baxter and Kenneth Campbell with CCTS.

The rest is here:
UK research getting to bottom of COVID clots - ABC 36 News - WTVQ

Read More...

Everything you need to know about DNA (almost) – BBC Focus Magazine

Friday, September 18th, 2020

Deoxyribonucleic acid, or DNA as its usually called, has an appealing mystique. Its in our DNA is now a standard refrain for marketers and individuals trumpeting some essential virtue: honesty, courage, integrity, wholesomeness.

The hype is often misplaced, but undoubtedly DNA is a wondrous molecule with unique, amazing features.

DNA is the only molecule capable of reproducing itself. DNA is present in almost all living cells of all living things. Only DNA, and no other molecule, carries the ability to copy and then pass heritable information to subsequent generations. DNA is, indeed, the essence of life itself.

Despite these apparently magical tricks, DNA follows the ordinary laws of science and nature. Sometimes those rules are not obvious, but a little scientific digging and reliance on robust evidence will ferret them out.

Physically, DNA is a chemical in the form of a twisted, extendable ladder, the iconic double helix. The ladder is composed of rungs and sugar-phosphate siderails.

The rungs consist of a pair of the small chemical bases: adenine, thymine, cytosine, and guanine, abbreviated A, T, C, and G, respectively Crucially, adenine (A) pairs only with thymine (T), and cytosine (C) only pairs with guanine (G). Only the pairs of either A:T or C:G fit as rungs between the two siderails.

The DNA double helix, composed of nucleotide rungs and sugar-phosphate siderails Getty Images

The weight and structure of the DNA ladder naturally twists it into the double helix shape. And the ladder molecule can extend great distances. In a human cell, for example, the number of DNA bases pair rungs in the DNA runs over three billion, measuring over six feet in length.

However, in multicellular organisms like humans, the DNA does not remain as one long strand, but is cut and tightly packed into chromosomes.

Human DNA extracted as a single molecule from a single cell extends to just under two metres long, but is ordinarily segmented and stuffed into 23 pairs of chromosomes in each cell.

All bacteria, plants and animals, including humans, use DNA as the repository of their hereditary information. That is, the recipe to confer every genetic trait, from eye colour to blood type, is carried by segments of DNA stored within each cell of the organism. These DNA segments carrying genetic information are called genes, the root word of genetics.

What differs between human DNA and tomato DNA, or, for that matter, the DNA between two humans, is the precise sequence of DNA base pairs A, T, C, and G. By way of analogy, two different recipes in an English language cookbook may use the same 26 letters to make words but differ in the exact sequence of those same 26 letters, resulting in different recipes.

Read more about genetics:

Although DNA is physically the same double helix composed of long segments of A:T and C:G base pairs in all living things, the exact sequence of those bases varies from one organism to another. It is the order of bases that provides the instructions to produce, say, insulin in human pancreatic cells or photosynthetic enzymes in plants. A plants DNA lacks the base sequences instructions to make insulin, and human DNA lacks instructions for photosynthetic enzymes.

In any organism, such as a given human, the DNA in every cell has the same base sequence as every other living cell in that human.

The difference between a liver cell, and a skin cell is that while both activate (express) those genes required for basic living processes, the liver cell expresses those genes for liver proteins. Other genes remain present, but are not expressed. Meanwhile, skin cells express the genes unique to skin proteins, but liver (and other) genes are silenced.

The language of genetics is the same in all of life. A gene from any cell of any living thing can be copied, transferred and understood by any other living thing to make the same protein.

For example, human insulin is now made by microbes genetically engineered with the human DNA recipe for human insulin. That is, a copy of the human insulin gene is transferred to microbes, and those microbes read the human insulin gene recipe and make insulin, even though the microbes having no blood or blood sugar have no use for insulin. Similarly, most hard cheeses now are made with chymosin (a milk clotting enzyme) generated by genetically modified microbes.

From a scientific perspective, we can confidently state that life began at least once, about 3.5 billion years ago.

A more interesting question, scientifically, is Did life arise more than once?

Answer: unlikely. The evidence is based on DNA being the sole common feature of all living things. More importantly, the language DNA uses to convey information is common to all; the same language is read and understood by all living things. And most importantly, the DNA language is not just the common language used by all species; it is the only language used by any species.

There are no other languages of genetics.

When considering the number of potential languages DNA might have used instead, the fact that all known life forms use the same language of DNA to communicate the same information is compelling evidence that life arose only once.

The fact that all living things use DNA as their physical hardware, and share a single language of DNA as their intellectual software, is evidence that all living things derive from a common ancestor way back when.

Other evidence includes gene homology (a similar DNA base sequence of similar genes in diverse species) and a common synteny (the linear order of adjacent genes in the DNA of a chromosome).

The consensus in the scientific community is that life started once and that evolution provided our current diversity of living things. To be sure, scientists argue strenuously over the mechanics of evolution, and timing, and duration, and other minutia concerning evolutionary processes.

Nevertheless, these arguments do not challenge the scientific consensus: Evolution is real.

Curious humans have always been interested in heredity, pondering how children acquired the features of their parents. But scientists didnt learn that DNA carried the hereditary information until the mid 20th Century. And we didnt know the structure of DNA until 1953. And we didnt know how the genetic information was conveyed within the DNA molecule for some years after that.

More recently, molecular geneticists have learned not only how to read the information carried by a DNA strand, but also how to edit or supplement it. These innovations allow development of a number of commercial products such as the aforementioned insulin and cheese.

DNA is often in the news these days. But it wasnt always so popular. A series of events in the mid-1990s thrust DNA into the spotlight.

Colin Pitchforks murder trial in the UK and O J Simpsons murder trial in the USA sparked public interest in the forensic use of DNA.

Cloning of Dolly the sheep in Scotland raised the spectre of the technical feasibility of cloning humans, a science fiction nightmare.

Then came the appearance on our dinner plates of genetically engineered crops and foods, the fearsome genetically modified organisms, GMOs. All of these high-profile stories were based on the use or perhaps abuse of DNA.

Read more about DNA:

The rocketing popularity of DNA is reflected in the rise of direct-to-consumer DNA testing. For a relatively small fee, several companies will conduct a DNA analysis from the cells in your cheek swab or spit sample. However, these DNA tests are not 100 per cent accurate.

We are all genetically closer to our fellow humans than we might realise. All humans share over 99.9 per cent of their DNA base sequence, so all of the genetic differences between you and your neighbour, or between a Kalahari bushman and a Laplander, are attributable to just 0.1 per cent of the respective DNA.

Even so, the differences, although small, can have dramatic consequences. Your DNA sequence determines your basic blood type (A, B, AB, or O), hair and eye colour, whether your earlobes dangle, and whether you can roll your tongue.

Less trivially, your DNA sequence makes you more (or, if youre lucky, less) susceptible to certain types of cancer, heart disease, blindness, and over 200 other health-related conditions.

The best metaphor illustrating the information storage function of DNA is the encyclopedia of recipes.

Many people cherish their family recipe books handed down from ancestors. The secret, family recipes are sometimes supplemented or annotated, and then shared with children, generation after generation, thus perpetually preserving, albeit with minor changes, the familys culinary tradition.

In principle, the full complement of genetic information in an organism the genome is no different. The genome uses DNA instead of paper to convey the familys precious intellectual property. Our genome is like that multivolume family encyclopedia of recipes. A gene provides instructions and information to the cell, telling the cell to make specific proteins in specific tissues, at specific times, and under specific conditions.

Now, imagine your own family cookbook collection consisting of 23 volumes, with about 20,000 recipes in total, the approximate number of gene recipes in the human genome. We store most of our DNA in 23 pairs of chromosomes, for a total of 46 volumes in each cell. Each chromosome consists of a long DNA chain, with each metaphorical recipe corresponding to a shorter segment of DNA along the chain.

As scientists continue to study and understand DNA, they continue to innovate and devise practical applications.

Police now use DNA to identify long forgotten cold cases. Genealogists use DNA to compile and confirm family trees dating back centuries. Historians use DNA to identify the fragmented remains of lost soldiers, from WWI infantry missing in action at Vimy Ridge to King Richard III under a car park in Leicester.

Doctors use new drugs and medical treatments, including those to combat cancer and the coronavirus, developed from molecular genetic manipulation. And fertility experts help infertile couples have biological children. Understanding DNA and how it functions leads to new technologies while simultaneously enhancing our fascination with the molecule of life.

Still have questions? More on DNA and genetics:

Alan McHughens book, DNA Demystified: Unravelling the Double Helix, is out now (19.99, Oxford University Press).

Visit link:
Everything you need to know about DNA (almost) - BBC Focus Magazine

Read More...

Postdoctoral studies on the molecular mechanisms that regulate aging – Nature.com

Friday, September 18th, 2020

The Department of Biosciences and Nutrition performs research and education in several areas of medical science including aging, molecular endocrinology, cancer biology, functional genomics, systems biology, epigenetics, structural biochemistry, bioorganic chemistry, cellular virology, and nutrition. It offers an excellent international research and working environment, including around 250 scientists, students, administrative and technical personnel. The Department resides in the new biomedical research building Neo, aimed at being a creative and open environment that enables meetings, synergies, and exploration of areas of mutual interest across disciplines.

Do you want to contribute to top quality medical research?

Aging is one of the main risk factors for morbidity and mortality. Thus, a better understanding of the mechanisms that regulate this process is highly desirable. One of our efforts focuses on arguably the most important aging regulator known to date, the transcription factor DAF-16/FOXO. It resides downstream of the nutrient-sensing insulin/IGF signaling pathway and in response to low nutrients activates gene expression programs that slow down the aging process. DAF-16/FOXO depends on a diverse range of binding partners and regulators to fulfill its role, and we are studying their functions by diverse biochemical, genetic, and cytological techniques. (See Lin et al., Nature Communications 2018, or Sen et al., Nature Communications 2020, for examples of such work from our lab.)

Your mission

We are looking for a Postdoc to join our research group, the lab of Christian Riedel. Focus of this position is to explore a new binding partner of DAF-16/FOXO which we found to be required for DAF-16/FOXO to promote longevity in response to low nutrient signals. This work is conducted both in the model organism C. elegans and in human cells. You will synergize with aging biologists and bioinformaticians from the Riedel lab and be part of a larger aging-focused research environment at our department, which also contains the labs of Martin Berg and Maria Eriksson.

We are looking for a talented and highly motivated scientist with a doctoral degree and strong background in Molecular Biology, Cell Biology, Genetics, and/or Biochemistry. Good expertise in either C. elegans methods or in mammalian cell culture techniques is desired. Also, a background in the biology of aging is appreciated, even though it is not essential.

Applicants are expected to work independently but as part of an enthusiastic team and to be proficient in English. They are expected to play a leading role in the design and execution of their experiments as well as the analysis and the presentation/publication of the resulting data. Before and while being in the lab, the applicant will be encouraged to apply for competitive national and international postdoctoral fellowships and career grants and will receive support in those endeavors.

This position will be financed by a postdoc scholarship paid out by Karolinska Institutet.

Scholarships for postdoctoral qualification can be established for foreign researchers who place their qualifications in Sweden. The purpose of scholarships for postdoctoral qualification is to promote internationalization and contribute to research qualification after a doctorate or equivalent.A scholarship for carrying out postdoctoral research can be granted for a maximum of two years within a four year period following the receipt of a doctoral degree or equivalent.To be eligible for a postdoctoral scholarship, the person must have obtained a doctorate or a foreign degree deemed to be equivalent to a doctorate. Applicants who have not completed a doctorate at the end of the application period may also apply, provided that all requirements for a completed degree are met before the (intended) start date of the post doctoral education.

The head of the department determines whether their previous training and scholarly qualifications correspond to a Swedish doctorate or higher.

What do we offer?

A creative and inspiring environment full of expertise and curiosity. Karolinska Institutet is one of the worlds leading medical universities. Our vision is to pursue the development of knowledge about life and to promote a better health for all. At Karolinska Institutet, we conduct successful medical research and hold the largest range of medical education in Sweden.

Location: Department of Biosciences and Nutrition, Neo Building, Flemingsberg

Links: https://ki.se/en/bionut/department-of-biosciences-and-nutrition https://ki.se/en/bionut/christian-riedel-group http://riedellab.org/

The amount is tax free and it is set for twelve months at a time, paid out on a six months basis. In exceptional cases, shorter periods may be acceptable.

An application must contain the following documents in English:

You are welcome to apply at the latest by 16 October 2020.

The application has to be submitted through the Varbi recruitment system.

View post:
Postdoctoral studies on the molecular mechanisms that regulate aging - Nature.com

Read More...

The Undark Interview: A Conversation with Rita Colwell – Undark Magazine

Friday, September 18th, 2020

Rita Colwell is a pioneering microbiologist whose work on cholera helped illuminate the interplay between the environment and public health. She was also the first woman to serve as director of the National Science Foundation, and is currently a Distinguished University Professor at both the University of Maryland and Johns Hopkins Universitys Bloomberg School of Public Health.

In her half-century-plus in the sciences, Colwell has also seen very clearly the array of obstacles confronted by women as they try to navigate a traditionally male world. (When she applied for a graduate fellowship in bacteriology, she says was told, We dont waste fellowships on women.)

A Lab of Ones Own: One Womans Personal Journey Through Sexism in Science, by Rita Colwell and Sharon Bertsch McGrayne (Simon & Schuster, 288 pages).

Colwells new book, A Lab of Ones Own, co-authored with writer Sharon Bertsch McGrayne, documents much of what she has seen and heard over the years, from sexual harassment to the invisible structural obstacles placed in the way of women working in the sciences. (The books subtitle is One Womans Personal Journey Through Sexism in Science.)

Not long ago, women were discouraged from studying science at all; those who did pursue such studies were seen as oddities. Later, when the numbers of women earning science degrees began to rise, they found themselves receiving less funding than their male colleagues, and less likely to land a position as a professor or a lab director. (It wasnt that long ago, Colwell recalls, when a grant application could be turned down because a man on the granting committee simply didnt like women scientists.) But Colwell also found allies along the way, and her book is something of a celebration of what can be achieved when science strives for inclusivity.

The following interview has been edited for length and clarity.

UNDARK: Though sexism has a long history, you write that the 1950s and 60s saw unprecedented levels of sexism in the sciences. What was going on at that time?

Rita Colwell: The attitude was, a woman worked in the home period. A woman couldnt even get a credit card in her own name; she had to have her husband, or her father, vouch for her. In general, the understanding was, if you were [a woman] interested in science, that was peculiar. It wasnt unusual for women to go to college but most did not go from there into any kind of work, unless it was nursing or teaching. It was a very limiting time, for women. A lot of this was unspoken; it was just sort of assumed.

UD: Regarding graduate education, you say that women were simply seen as not worth investing in. What does that mean?

RC: The expectation was that you would get married and have children. If you werent there, with your children, you were seen as a bad mother. You went to college to find a husband; that was the expectation.

UD: You point out that not only could one face obstacles for being a woman Ph.D. student, you could face a backlash if you supervised too many women Ph.D. students. What was that about?

RC: The assumption was that anyone who was really brilliant, with great ideas, would work for a male professor. So if you took women students, it was assumed they werent the best and the brightest. Having women students would mark you as not serious; your students were just going to get married, and youre just wasting all this time.

UD: As you say, a lot of this was unspoken but eventually there was solid data to quantify this discrimination. How did that come about?

RC: It was in the 90s that Nancy Hopkins at MIT carried out her now-famous experiment: She measured the labs, and discovered that the men had almost twice as much space; they also got the bulk of the research money. More women were entering these careers [in the sciences], but men got most of the funding and most of the space.

Later, Jo Handelsman did the experiment where they sent identical letters to male researchers [from recent graduates applying to be a lab manager], the only difference was that some were signed John and others were signed Jennifer. The question was, would you hire this person, and what would you pay them? Far fewer said they would hire the woman; and the salary they were prepared to offer was much, much lower.

But Id like to emphasize one thing: Once I was able to break through, at each stage of my career, there was tremendous support. My father was very education-minded; it didnt matter if you were a girl or a boy; everyone went to school. My husband, a physicist, was a fantastic supporter; we were married for 62 very happy years. And my Ph.D. supervisor, John Liston, was absolutely the best. He was a newcomer to the University of Washington, starting a new program in marine microbiology so I ended up being the first graduate student with a Ph.D. in marine microbiology, possibly in the whole United States.

The assumption was that anyone who was really brilliant, with great ideas, would work for a male professor. So if you took women students, it was assumed they werent the best and the brightest.

UD: Youre known for your groundbreaking work on cholera, but it was also fascinating to read about your work investigating the 2001 anthrax attacks, in which a number of politicians and journalists were mailed packages containing the deadly substance in the weeks following the 9/11 attacks. How did you end up on the front lines of that investigation?

RC: I was appointed [as director of the National Science Foundation] by Bill Clinton, and I served two years under Clinton and four under George W. Bush. In October or November [of 2001], we heard about anthrax attacks. I remember saying, Weve got to sequence that bacterium, or well never know who did it.

I had been working on an advisory board for the CIA, so I was able to call on some colleagues, and we formed an inter-agency group. We decided not to make the group official, so that we could keep it a secret. And we worked for five years on this classified project. And using molecular genetics, we tracked down the source. Now, well never know whether the perpetrator was in fact Bruce Ivins, and if he worked alone, or with others. [Ivins died in 2008.] He was an anthrax microbiologist, and the source turned out to be in his lab.

UD: You were using a computer in the late 1950s, long before they became ubiquitous in the life sciences. Did you have a sense that computers would eventually impact every branch of science?

RC: At the University of Washington, I wrote a computer program the first in the country, for bacteriology using the old IBM 650, which has less power than the chip in your microwave oven. When I was working with that computer, I had to program it, and I didnt know diddly. But in my husbands lab, there was a postdoc named George Constabaris, who taught me. And there was another chap who was using the IBM to do pipe-fitting for the ships in Seattle harbor. He was programming how to cut and fit pipe most efficiently.

So it was clear to me that this was an amazing tool. I used the computer for taxonomic purposes, for identification which now everybody does. Its amusing I used to give talks about species of bacteria, and people would yawn. But now the hotshots in Silicon Valley know the differences between different kinds of bacteria. It was clear to me that we had to have massive computation [in the sciences]. I was able to get into the NSF budget, over my term, $2 billion, for computation, for universities to start building the internet railway, so to speak.

UD: So much has changed in science, and in the culture of science, over your career. Today, are you optimistic or at least, more optimistic?

RC: I would say its cautious optimism. I dont know whats going to happen in the next administration; it could be a disaster for women. I strongly encourage girls to go into science. I abhor the assumption that girls cant do math; its absurd. Or that if youre African American you cant do math or you cant do science its crazy. Theres still sexism, which ranges from the criminal to the clueless. Like when someone comments to a woman scientist as shes going up to the podium to give a talk, that she looks attractive. Thats the last thing you want to hear. You want to hear Thats a great idea, or Can we collaborate on the next stage of this experiment?

Read the original:
The Undark Interview: A Conversation with Rita Colwell - Undark Magazine

Read More...

Jumpcode Genomics Exits Stealth Mode, Unveils Technology that Addresses the ‘Needle in the Haystack’ Problem of Molecular Biology – Bio-IT World

Friday, September 18th, 2020

Patented CRISPRclean Technology is a Foundational Tool that Improves the Performance of Next-Generation Sequencing and Other Molecular Workflows by Increasing Sensitivity, Reducing Costs and Enabling Novel Discovery

CARLSBAD, CA, UNITED STATES - Sep 17, 2020 - Jumpcode Genomics - a genome technology company founded by industry veterans in 2016 focused on improving the understanding of human disease - today exited stealth mode and announced the commercial launch of its CRISPRclean technology. Initially available via three kits, CRISPRclean unlocks the power of next generation sequencing (NGS) by improving sensitivity, reducing costs and simplifying workflows. The company also announced that it has strengthened its leadership team with the addition of Yaron Hakak, Ph.D., as CEO. In addition, the company has added new advisors, including Dr. Stanley Nelson, vice chairman of Human Genetics at UCLA as consulting chief scientist, and Gary Schroth, Ph.D., vice president and distinguished scientist at Illumina, as a member of the companys scientific advisory board.

CRISPRclean technology is based on the in-vitro utilization of the CRISPR/Cas system to cleave and physically remove nucleic acid sequences pre- or post-NGS library preparation. This enables researchers to remove overabundant and uninformative sequences to allow discovery and detection of molecules previously undetectable (the needles). Like polymerase chain reaction (PCR), the technology broadly applies to many molecular biology techniques, particularly sequencing technologies.

Initial research applications focus on ribosomal RNA depletion, single cell analysis and repeat removal for whole genome sequencing. Additionally, Jumpcode Genomics is pursuing clinical applications, including the removal of human host molecules for a universal pathogen test and depletion of wild type alleles for somatic mutation detection in oncology. The technology seamlessly integrates into existing workflows and is agnostic to library preparation methods and sequencing platforms.

We aim to revolutionize the practice of molecular biology with our technology and to drive better results for researchers today and ultimately patients tomorrow, said Dr. Hakak, CEO of Jumpcode Genomics. When researchers perform NGS on biological samples, most molecules sequenced are uninformative, which results in a needle in a haystack problem. CRISPRclean solves this problem by simply removing the haystack.

The expansion of the leadership team and scientific advisory board enables Jumpcode Genomics to commercialize its technology and strengthen direct access to thought leaders in the scientific community.

About Jumpcode Genomics: Founded in 2016, Jumpcode Genomics aims to improve the understanding of human biology and the contribution to disease. The companys proprietary CRISPRclean technology utilizes the CRISPR/Cas system to deplete unwanted nucleic acid molecules from sequencing libraries. The process fits seamlessly within standard next generation sequencing workflows and works with most commercially available library preparation solutions. For more information, please visit: http://www.jumpcodegenomics.com

View post:
Jumpcode Genomics Exits Stealth Mode, Unveils Technology that Addresses the 'Needle in the Haystack' Problem of Molecular Biology - Bio-IT World

Read More...

NIH Funds Research into Differences in Glioblastoma between Males and Females – Health Essentials from Cleveland Clinic

Friday, September 18th, 2020

A team led by researchers from Case Western Reserve University School of Medicine and Cleveland Clinics Lerner Research Institute has secured $10.4 million over five years from the National Institutes of Health/National Cancer Institute to explore at the molecular level the differences in glioblastoma between males and females.

The researchers will delve into the genetics, epigenetics and cell biology of glioblastoma the most common and deadliest brain tumor in adults to better understand the physiologic processes which may lead to more personalized therapies.

The researchers have previously published research showing significant differences between the sexes in glioblastoma incidence, survival and some key molecular pathways. They found that glioblastoma is 60 percent higher in males than in females. In addition, females have a significant survival advantage over males with a median improved survival rate of up to 10 months. However, while these sex differences are understood, they are not yet considered when treating glioblastoma.

The research team is led by co-principal investigators Justin Lathia, Ph.D., of Cleveland Clinics Lerner Research Institute, and Jill Barnholtz-Sloan, Ph.D., of Case Western Reserve University School of Medicine. The team also includes colleagues from Penn State College of Medicine, Washington University School of Medicine in St. Louis, and the Translational Genomics Research Institute (TGen).

Glioblastomas are rare about 3.5-4 per 100,000 in the United States from 2012-16, the most recent data available from the Central Brain Tumor Registry of the United States (CBTRUS). Despite available treatments, glioblastomas have devastating consequences for patients. The median survival time is 12 to 14 months, and only about 5% of patients survive more than five years.

We have the molecular profiling technology and the computing and analytical strength to lead in this effort to better understand the role of sex differences in cancer, particularly for glioblastoma, said Barnholtz-Sloan, the Sally S. Morley Designated Professor in Brain Tumor Research and associate director of Data Sciences at the Case Comprehensive Cancer Center, Case Western Reserve School of Medicine. This next phase of research relies on vast, varied and complex datasets in animals and humans and promises to be a game-changer in how we understand the role of sex in tumor formation and disease outcomes. This comprehensive approach has applications to all forms of cancer, as well as other diseases.

Sex differences are inherent drivers of glioblastoma incidence and survival, and we are taking a multidimensional approach to uncover a better understanding of this differentiation, said Lathia, vice chair of the Department of Cardiovascular and Metabolic Sciences and co-director of the Brain Tumor Research & Therapeutic Development Center of Excellence at Lerner Research Institute, and co-leader of the Molecular Oncology Program at the Case Comprehensive Cancer Center. We are incorporating data from tumor cells and their surrounding micro-environment, as well as genetic programs responsible for tumor growth, and underlying epigenetic differences that may be responsible for sex differences. We aim to gain a better understanding of how these variables interrelate to better understand disease mechanism, which in turn defines better diagnostics and more personalized therapies for patients.

The multi-disciplinary project involves established investigators with complementary expertise and a strong collaborative history. Along with Lathia and Barnholtz-Sloan, participating institutions and their PIs include:

Three related research projects, undertaken by this collaborative team, will delve into the basic biology and cellular mechanisms that drive sex differences in glioblastoma formation and progression. These related research projects will inform, synergize and depend on each other. Findings from the labs based on their animal models will then be queried against data from human clinical samples across multiple institutions. The vast amount of data generated from these studies requires robust data management and sophisticated data analysis for a comprehensive view of sex differences across these diverse but related inquiries.

Comprehensive findings will inform future clinical research design, the search for targets for new therapeutics, or the use of existing therapeutics that may be applied differently depending on a patients sex.

This grant was made by the NIHs National Cancer Institute. Grant number: 1P01CA245705.

Cleveland Clinic: Alicia Reale, 216-408-7444, Realeca@ccf.org

Case Western Reserve: Bill Lubinger, 216-368-4443, william.lubinger@case.edu

The rest is here:
NIH Funds Research into Differences in Glioblastoma between Males and Females - Health Essentials from Cleveland Clinic

Read More...

Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for…

Friday, September 18th, 2020

Published Study on Modifiable Risk Factors for the Emergence of Ceftolozane-Tazobactam Resistance

Presented Study on Long-Read Sequencing to Predict Phenotypic Antimicrobial Susceptibility Testing Results

Work Aimed at Demonstrating Diagnostic Value of Next-Generation Sequencing for Antimicrobial Susceptibility Testing and Translation into Clinical Practice

VIENNA, Austria and GAITHERSBURG, Md., Sept. 16, 2020 (GLOBE NEWSWIRE) -- OpGen, Inc. (Nasdaq: OPGN, OpGen), announced today that scientists at its subsidiary Ares Genetics GmbH (Vienna, Austria; Ares Genetics), in collaboration with researchers from the Johns Hopkins University School of Medicine, have published a peer-reviewed study on modifiable risk factors for the emergence of ceftolozane-tazobactam resistance in P. aeruginosa in the journal Clinical Infectious Diseases.

P. aeruginosa is listed by the World Health Organization as critical priority pathogen. To overcome antimicrobial resistance, ceftolozane-tazobactam has been introduced as a novel -lactam--lactamase inhibitor combination agent and received initial U.S. FDA approval in 2014. While pre-clinical investigations indicated ceftolozane-tazobactam activity against approximately 85%-95% of U.S. and Canadian carbapenem-non-susceptible P. aeruginosa isolates, soon after the clinical introduction of ceftolozane-tazobactam, reports of resistance during therapy emerged.

The study published in Clinical Infectious Diseases sought to understand mechanisms of resistance leading to ceftolozane-tazobactam resistance, the frequency of cross-resistance between ceftolozane-tazobactam and other novel beta-lactam beta-lactamase inhibitor combinations and identify modifiable risk factors that may slow or prevent the acquisition of ceftolozane-tazobactam resistance. Findings demonstrate the potential of Next-Generation Sequencing (NGS) to investigate mechanisms of resistance by analyzing whole-genome sequencing data from P. aeruginosa isolates that developed resistance under treatment with ceftolozane-tazobactam. Mutations identified in ceftolozane-tazobactam resistant isolates involved, amongst others, AmpC, a known binding site for ceftolozane, PBP3, the target of ceftolozane, and DNA polymerase. The researchers propose extending ceftolozane-tazobactam infusions as a potential protective measure against acquired mutational resistance.

The present study is the result of an ongoing collaboration between Ares Genetics and the Johns Hopkins University School of Medicine, with the goal of investigating the diagnostic potential of NGS for antimicrobial susceptibility testing. Earlier this year, Dr. Patricia Simner of Johns Hopkins Medicine and Ares Genetics presented results from a study assessing the potential of long-read sequencing to predict antimicrobial susceptibility results at the online ASM Microbe 2020 meeting.

Dr. Andreas Posch, CEO Ares Genetics and co-author of both studies, commented, While we have already shown that NGS allows for CLIA-compliant identification of bacterial pathogens and antimicrobial resistance markers as well as accurate prediction of phenotypic resistance in previous publications, the present studies further underline the diagnostic value of NGS as well as the need for rapid antimicrobial resistance testing and improving antibiotic treatment regiments. I am particularly excited about our joint work on using long-read sequencing technology for phenotype prediction as this technology could potentially allow for molecular antibiotic susceptibility testing directly from native patient samples in just a few hours.

About OpGen, Inc.

OpGen, Inc. (Gaithersburg, MD, USA) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease. Along with subsidiaries, Curetis GmbH and Ares Genetics GmbH, we are developing and commercializing molecular microbiology solutions helping to guide clinicians with more rapid and actionable information about life threatening infections to improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. OpGens product portfolio includes Unyvero, Acuitas AMR Gene Panel and Acuitas Lighthouse, and the ARES Technology Platform including ARESdb, using NGS technology and AI-powered bioinformatics solutions for antibiotic response prediction.

Story continues

For more information, please visit http://www.opgen.com.

Forward-Looking Statements by OpGen

This press release includes statements regarding studies and publications of OpGens subsidiary Ares Genetics GmbH. These statements and other statements regarding OpGens future plans and goals constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are intended to qualify for the safe harbor from liability established by the Private Securities Litigation Reform Act of 1995. Such statements are subject to risks and uncertainties that are often difficult to predict, are beyond our control, and which may cause results to differ materially from expectations. Factors that could cause our results to differ materially from those described include, but are not limited to, our ability to successfully, timely and cost-effectively develop, seek and obtain regulatory clearance for and commercialize our product and services offerings, the rate of adoption of our products and services by hospitals and other healthcare providers, the realization of expected benefits of our business combination transaction with Curetis GmbH, the success of our commercialization efforts, the impact of COVID-19 on the Companys operations, financial results, and commercialization efforts as well as on capital markets and general economic conditions, the effect on our business of existing and new regulatory requirements, and other economic and competitive factors. For a discussion of the most significant risks and uncertainties associated with OpGen's business, please review our filings with the Securities and Exchange Commission. You are cautioned not to place undue reliance on these forward-looking statements, which are based on our expectations as of the date of this press release and speak only as of the date of this press release. We undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.

OpGen Contact:Oliver SchachtCEOInvestorRelations@opgen.com

Press Contact:Matthew BretziusFischTank Marketing and PRmatt@fischtankpr.com

Investor Contact:Megan PaulEdison Groupmpaul@edisongroup.com

See the article here:
Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Generation Sequencing for...

Read More...

Page 17«..10..16171819..3040..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick